BioNTech
BNTX
195 hedge funds and large institutions have $1.78B invested in BioNTech in 2020 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 43 increasing their positions, 46 reducing their positions, and 34 closing their positions.
144% more first-time investments, than exits
New positions opened: 83 | Existing positions closed: 34
33% more funds holding
Funds holding: 147 → 195 (+48)
6% more capital invested
Capital invested by funds: $1.68B → $1.78B (+$94.5M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less call options, than puts
Call options by funds: $181M | Put options by funds: $193M
7% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 46
1.06% less ownership
Funds ownership: 10.2% → 9.13% (-1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$64.6M |
| 2 |
Primecap Management
Pasadena,
California
|
+$49.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$37M |
| 4 |
Morgan Stanley
New York
|
+$20.6M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$18.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$157M |
| 2 |
Janus Henderson Group
London,
|
-$78.8M |
| 3 |
AG
Artal Group
Luxembourg
|
-$71.8M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$64.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$56.4M |
BNTX Hedge Fund Activity: Q4 2020 in Review
195 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q4 2020, worth a combined $1.78B — up 5.6% from $1.68B a quarter earlier.
Buyers outnumbered sellers: 83 funds opened new BNTX positions and 34 closed out — a net gain of 49 holders — while 43 added to existing stakes and 46 trimmed.
The largest buyer was BlackRock, adding an estimated $64.6M. The largest seller was Fidelity Investments, cutting an estimated $157M.
- 195 institutional investors held BioNTech (BNTX) as of Q4 2020, up from 147 in Q3 2020.
- Funds reported $1.78B of BioNTech stock for Q4 2020, up 5.6% quarter-over-quarter.
- 83 funds opened new BioNTech positions in Q4 2020 and 34 closed out, a net change of +49 holders.
- The largest BioNTech buyer in Q4 2020 was BlackRock, an estimated $64.6M added.
- The largest BioNTech seller in Q4 2020 was Fidelity Investments, an estimated $157M sold.
Based on aggregated 13F filings for Q4 2020.